Innovent Biologics Inc. unveiled for the first time safety and efficacy data of IBI-354, an HER2 monoclonal antibody-camptothecin derivative conjugate that shows promising efficacy signals across a ...
IBI354, an anti-HER2 monoclonal antibody-camptothecin derivative conjugate, has shown good anti-tumor activity in platinum-resistant ovarian cancer with HER2 expression of 1+. In our Phase 1 study ...
JAKARTA, Indonesia , Sept. 17, 2024 /PRNewswire/ -- Get ready to experience exciting adventures with beloved Pokémon characters at Pikachu's Indonesia Journey, held on September 21 and 22, 2024, at ...
Professor of Pharmaceutics Paula & John J. Lovoi Sr. Endowed Professor in Drug Discovery and Development Director, Institute of Drug Education and Research Department of Pharmacological and ...